These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10983145)

  • 1. Motor fluctuations in Parkinson's disease.
    Crabb L
    Prof Nurse; 2000 Jan; 15(4):273-7. PubMed ID: 10983145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Young-onset Parkinson's disease: a guide to care and support.
    McCall B
    Nurs Times; 2003 Jul 29-Aug 4; 99(30):28-31. PubMed ID: 12961940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily motor performance after switching levodopa to melevodopa: an open-label on advanced Parkinson's disease with "delayed-on" and/or"wearing-off".
    Bosco D; Plastino M; Bosco F; Fava A; Rotondo A
    Minerva Med; 2011 Apr; 102(2):125-32. PubMed ID: 21483399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease revisited.
    Herndon CM; Young K; Herndon AD; Dole EJ
    J Neurosci Nurs; 2000 Aug; 32(4):216-21. PubMed ID: 10994535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S23-37. PubMed ID: 12211137
    [No Abstract]   [Full Text] [Related]  

  • 6. Amantadine and other antiglutamate agents: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S13-22. PubMed ID: 12211136
    [No Abstract]   [Full Text] [Related]  

  • 7. Recognition and treatment of response fluctuations in Parkinson's disease: review article.
    Verhagen Metman L
    Amino Acids; 2002; 23(1-3):141-5. PubMed ID: 12373528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
    Marras C; Lang A; Krahn M; Tomlinson G; Naglie G;
    Mov Disord; 2004 Jan; 19(1):22-8. PubMed ID: 14743356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medical, social, and functional profile of Parkinson's disease patients.
    Lee KS; Merriman A; Owen A; Chew B; Tan TC
    Singapore Med J; 1994 Jun; 35(3):265-8. PubMed ID: 7997900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apomorphine for the acute treatment of "off" episodes in Parkinson's disease.
    Stacy M; Silver D
    Parkinsonism Relat Disord; 2008; 14(2):85-92. PubMed ID: 18083605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa therapy for Parkinson's disease: challenges and future prospects.
    Olanow CW; Lees A; Obeso J
    Mov Disord; 2008; 23 Suppl 3():S495-6. PubMed ID: 18781670
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease.
    Priano L; Albani G; Calderoni S; Baudo S; Lopiano L; Rizzone M; Astolfi V; Cavalli R; Gasco MR; Fraschini F; Bergamasco B; Mauro A
    Neurol Sci; 2002 Sep; 23 Suppl 2():S99-100. PubMed ID: 12548362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychophysiological approach in Parkinson's disease: L-dopa effects on preprogramming and control activity.
    Fattapposta F; Pierelli F; My F; Mostarda M; Del Monte S; Parisi L; Serrao M; Locuratolo N; Amabile G
    Neurol Sci; 2002 Sep; 23 Suppl 2():S73-4. PubMed ID: 12548350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying poor symptom control in Parkinson's disease.
    Scott L
    Nurs Times; 2006 Mar 21-27; 102(12):30-2. PubMed ID: 16594560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic management of Parkinson's disease in long-term care residents: maintaining functionality to improve quality of life.
    Silver DE
    Director; 2007; 15(2):20-9. PubMed ID: 19343903
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA; Grosset DG
    Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Driving ability in Parkinson's disease: current status of research.
    Klimkeit EI; Bradshaw JL; Charlton J; Stolwyk R; Georgiou-Karistianis N
    Neurosci Biobehav Rev; 2009 Mar; 33(3):223-31. PubMed ID: 18775450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced Parkinson's disease.
    Diamond A; Jankovic J
    Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.